Top Markets
Coin of the day
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Clasificación en acciones #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Precio por acción
$3.45
Última sincronización: 2021-09-21
Capitalización bursátil
$4.29M
Cambio (1 día)
2.07%
Cambio (1 año)
0.00%
País
US
Comercio AzurRx BioPharma, Inc. (AZRX)

Categoría

Historial de desdoblamientos de acciones de AzurRx BioPharma, Inc. (AZRX)
La acción AzurRx BioPharma, Inc. (símbolo: AZRX) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 16, 2026.
Una acción AZRX comprada antes de Aug 16, 2026 equivaldría hoy a 0 acciones AZRX.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE